Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, November 22, 2021
Flywheel, a cloud-scale informatics platform for biomedical research and collaboration, announced the successful integration of its platform by Roche and Genentech, a member of the Roche Group, for ingestion, classification, standardization, curation...
read more
Flywheel and Imbio have partnered to accelerate lung disease discovery, diagnosis, and treatment in the Life Sciences.
read more
Fluxergy is making a $30 million investment to expand its capability to scale production of the Fluxergy Analyzer diagnostic testing system in response to the COVID-19 pandemic.
read more
Friday, December 20, 2013
FlowMetric, a market leader in flow cytometry and cell sorting services, announced today that they have hired Rachel A. Bunting to lead their Business Development Unit. Ms. Bunting will be tasked with overseeing a rapidly expanding portfolio of ...
read more
Flow Pharma has selected BGI Americas to provide the sequencing services required for all FlowVax neoantigen-based personalized therapeutic cancer vaccines under development by Flow Pharma.
read more
Tuesday, February 18, 2025
Flourish Research, a multi-site clinical trial organization focused primarily on cardiovascular, metabolic, neuroscience, and infectious disease therapeutic areas, announced the acquisition of Diablo Clinical Research, a multi-therapeutic clinical ...
read more
Thursday, September 08, 2022
Univercells Technologies, a provider of novel biomanufacturing technologies for flexible and scalable production of advanced therapies, announced the appointment of Florence Vicaire as Chief Commercial Officer (CCO).
read more
The European Commission (EC) has granted marketing authorization in the European Union (EU) for FLIXABI®, an infliximab biosimilar referencing Remicade®i.
read more
The Russian pharmaceutical market is developing rapidly; it takes 11th place in the rating of pharmaceutical market volumes worldwide and is predicted to go up to 9th place by 2016. Along with its growing potential, important changes in the industry ...
read more
Thursday, November 14, 2024
Flashpoint Therapeutics announced a significant expansion of its therapeutic pipeline through strategic acquisitions and a new partnership valued at $50M with The King Abdullah International Medical Research Center (KAIMRC) in Saudi Arabia.
read more
Flare Therapeutics Inc., a clinical-stage biotechnology company targeting transcription factors to discover precision medicines for cancer and other diseases, today announced the appointment of Douglas Manion, M.D., FRCP (C), as Chief Executive ...
read more
Tuesday, February 24, 2026
The Flamma Group announced that its Flamma USA site, located in Malvern, PA, has successfully passed its first FDA inspection.
read more
Friday, November 06, 2020
Flamma has entered into an agreement with Gilead earlier this year to be part of the network of manufacturers contributing to the Veklury (remdesivir) supply chain.
read more
The Flamma Group has officially opened its current Good Manufacturing Practice (cGMP) plant in Dalian, China, expanding its global pharmaceutical manufacturing footprint. The grand opening ceremony marked the launch of the Flamma Honkai 2 facility, ...
read more
The Flamma Group, a company producing and commercializing small molecule Active Pharmaceutical Ingredients (APIs) for the life science industry as well as a Contract Development and Manufacturing Organization (CDMO) of New Chemical Entities (NCEs) ...
read more